01 Stock Market

As of Oct 15, U.S. stock index futures performed as follows: E-mini Dow Jones futures rose 0.18% to 51,953.00, while E-mini S&P 500 futures fell 0.35% to 7,743.00 and E-mini Nasdaq 100 futures fell 1.25% to 29,804.25. The setup points to a mixed pre-bell tone, with the Dow holding up better than the growth-heavy Nasdaq complex. Weakness in the Nasdaq-linked contract suggests continued pressure on technology and semiconductor names, while the broader S&P 500 signal remains softer but less extreme than the Nasdaq move.

Notable Stock Movers: Apple up 0.71% at $345.41; NVIDIA fell 1.65% at $217.65; Micron Technology fell 4.35% at $874.33; Advanced Micro Devices fell 3.12% at $553.00; Marvell Technology fell 4.56% at $234.10; Taiwan Semiconductor Manufacturing fell 2.20% at $420.54; Rocket Lab USA fell 10.56% at $52.93; Bloom Energy fell 5.53% at $226.10. The pre-market tape was dominated by semiconductor and AI-related weakness, with multiple chip and infrastructure names extending losses. Apple stood out as a relative outperformer, helped by its defensive profile versus the more cyclical AI trade.

Broader stock action: SoXS rose 8.63% at $46.19 while SOXL fell 8.72% at $100.90, highlighting aggressive repositioning around semiconductors.

02 Other Markets

• 10-year U.S. Treasury yield fell 1.86%, to 5.09%.

• U.S. Dollar Index fell 0.4193% to 102.11.

• WTI crude oil futures rose 0.29% to 94.17 USD/barrel; COMEX gold futures rose 1.41% to 4166.00 USD/ounce.

03 Key News

1. Adlai Nortye signed clinical trial collaboration and supply agreements with Eli Lilly and Merck KGaA. The company said the partners will support a global phase I study of its investigational cancer drug AN4035, including free supply of cetuximab for trial sites in the United States, China, and Australia. The agreement broadens the trial’s execution path and gives Adlai Nortye access to established oncology infrastructure for testing a combination therapy approach.

2. Conavi Medical said it will showcase its FDA-cleared hybrid imaging system at an upcoming medical conference. The company plans to present its hybrid IVUS-OCT imaging system and related research at the TCT conference in San Diego. The scheduled presentations and education sessions are meant to highlight product capabilities and support clinical adoption efforts for its cardiovascular imaging platform.

3. Upay disclosed a delay in filing its quarterly report because the auditor review is unfinished. The company said its Form 10-Q for the period ended August 31 has not been completed because the auditor has not finished reviewing the financial statements. Upay said it expects to file within five calendar days of the due date and does not anticipate a significant change in operating results versus the prior-year period.

4. First Horizon reported quarterly results that were followed by a pre-market decline. The bank’s shares weakened after the latest results, indicating the market found something in the release that warranted caution. The news item did not provide the detailed financial drivers, but the move shows investors were quick to reassess the outlook after the report.

5. Apple reached a major market-cap milestone as its shares continued to firm. The company joined the $5 trillion club, underscoring the scale of investor confidence in its business model and product cycle. The report noted that the stock had recently been supported by new product launches and by its comparatively restrained AI spending, which has made it stand out among megacap peers.

6. Micron Technology fell again as memory-chip concerns deepened. The company’s shares moved lower amid worries about Chinese competition and broader weakness in the AI trade. The report said the pressure followed news that a Chinese rival is developing a new memory chip, and it also pointed to expectations that Micron may eventually lean more heavily on shareholder returns as restrictions ease.

7. Venture Global advanced after announcing a power equipment deal with GE Vernova and Baker Hughes. The arrangement links Venture Global with two major industrial suppliers, suggesting concrete progress on equipment and infrastructure needs. The deal is notable because it ties commercial execution directly to the company’s expansion plans rather than to broad industry themes.

8. Commercial Metals jumped after reporting results that beat estimates. The company’s quarterly performance was strong enough to attract immediate buying interest. The move reflects a classic earnings reaction, with investors rewarding a clearer-than-expected operating update.

9. Rocket Lab fell after news that its Neutron launch has been delayed. The new target for the launch slipped further into the future, raising execution concerns around a closely watched space program. The setback matters because Neutron is central to the company’s longer-term growth strategy and its competitiveness in launch services.

10. First Solar drew fresh investor attention after Kenneth Griffin disclosed a passive stake. The filing showed a 5.0% passive holding, a level that can draw market interest because it signals a meaningful capital commitment. While the filing did not change company operations, it added a high-profile ownership update that could influence sentiment around the stock.

Sources: Reuters, Dow Jones, Tiger Newspress, public market data

Disclaimer: For informational purposes only; not investment advice.